{"id":"W4385707156","doi":"10.1097/01.hs9.0000971348.10013.c4","title":"P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Propensity score matching; Oncology; Internal medicine; Progression-free survival; Rituximab; Population; Overall survival; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01071015,0.001731592,0.003389224,0.00078939,0.000302987,0.001144507,0.00119652,0.00195232,0.01171105],"category_scores_gemma":[0.01964509,0.0004332049,0.01054075,0.0006387965,0.0008835007,0.001092885,0.00144678,0.002715676,0.0006442788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001023445,"about_ca_system_score_gemma":0.001037118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001086626,"about_ca_topic_score_gemma":0.001358687,"domain_scores_codex":[0.9873296,0.01012901,0.0008443807,0.0007932155,0.0005587662,0.0003450605],"domain_scores_gemma":[0.9916768,0.006044858,0.001144674,0.0005704322,0.0002898807,0.0002733374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7532101,0.001266684,0.008536615,0.01932454,0.1645295,0.0001594917,0.000274608,0.003129245,0.001990556,0.002652508,0.003495262,0.04143105],"study_design_scores_gemma":[0.4883372,0.1240679,0.04452401,0.003193972,0.2877098,0.0004045383,0.0004173278,0.01799219,0.004045222,0.01430558,0.01477868,0.0002236616],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.889384,0.04806386,0.01814169,0.002121743,0.003530863,0.01660824,0.01065715,0.000366514,0.01112584],"genre_scores_gemma":[0.9797805,0.001948348,0.005751085,0.0007513672,0.0002501866,0.007965638,0.001573073,0.0000343037,0.001945647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01171105,"threshold_uncertainty_score":0.05664134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09647680593430397,"score_gpt":0.3711941144409404,"score_spread":0.2747173085066364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}